Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,781 to 1,800 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-molecule fluorescence imaging techniques reveal molecular mechanisms underlying deoxyribonucleic acid damage repair. | Front Bioeng Biotechnol | 2022 | 36185427 | PubTator, text mining | PubMed |
| m6A RNA methylation regulates the transcription factors JUN and JUNB in TGF-β-induced epithelial-mesenchymal transition of lung cancer cells. | J Biol Chem | 2022 | 36183833 | PubTator, text mining | PubMed |
| RNA modifications in aging-associated cardiovascular diseases. | Aging (Albany NY) | 2022 | 36178367 | PubTator, text mining | PubMed |
| Targeting epigenetic regulators for inflammation: Mechanisms and intervention therapy. | MedComm (2020) | 2022 | 36176733 | PubTator, text mining | PubMed |
| Necroptosis-related lncRNA signature predicts prognosis and immune response for cervical squamous cell carcinoma and endocervical adenocarcinomas. | Sci Rep | 2022 | 36175606 | PubTator, text mining | PubMed |
| m6A RNA methylation regulator-related signatures exhibit good prognosis prediction ability for head and neck squamous cell carcinoma. | Sci Rep | 2022 | 36175504 | PubTator, text mining | PubMed |
| More than a duologue: In-depth insights into epitranscriptomics and ferroptosis. | Front Cell Dev Biol | 2022 | 36172270 | PubTator, text mining | PubMed |
| FTO promotes liver inflammation by suppressing m6A mRNA methylation of IL-17RA. | Front Oncol | 2022 | 36172147 | PubTator, text mining | PubMed |
| Modification of m6A mediates tissue immune microenvironment in calcific aortic valve disease. | Ann Transl Med | 2022 | 36172101 | PubTator, text mining | PubMed |
| Comprehensive analysis of the expression of N6-methyladenosine RNA methylation regulators in pulmonary artery hypertension. | Front Genet | 2022 | 36171892 | PubTator, text mining | PubMed |
| Comprehensive analysis about prognostic and immunological role of WTAP in pan-cancer. | Front Genet | 2022 | 36171885 | PubTator, text mining | PubMed |
| The N6-methyladenosine-mediated lncRNA WEE2-AS1 promotes glioblastoma progression by stabilizing RPN2. | Theranostics | 2022 | 36168628 | PubTator, text mining | PubMed |
| m6A-induced lncDBET promotes the malignant progression of bladder cancer through FABP5-mediated lipid metabolism. | Theranostics | 2022 | 36168624 | PubTator, text mining | PubMed |
| Cryo-EM structures of human m6A writer complexes. | Cell Res | 2022 | 36167981 | PubTator, text mining | PubMed |
| METTL3 suppresses anlotinib sensitivity by regulating m6A modification of FGFR3 in oral squamous cell carcinoma. | Cancer Cell Int | 2022 | 36167542 | PubTator, text mining | PubMed |
| FIONA1-mediated methylation of the 3'UTR of FLC affects FLC transcript levels and flowering in Arabidopsis. | PLoS Genet | 2022 | 36166469 | PubTator, text mining | PubMed |
| Structural insights into molecular mechanism for N6-adenosine methylation by MT-A70 family methyltransferase METTL4. | Nat Commun | 2022 | 36163360 | PubTator, text mining | PubMed |
| A programmable system to methylate and demethylate N6-methyladenosine (m6A) on specific RNA transcripts in mammalian cells. | J Biol Chem | 2022 | 36162509 | PubTator, text mining | PubMed |
| M6A RNA Methylation-Based Epitranscriptomic Modifications in Plasticity-Related Genes via miR-124-C/EBPα-FTO-Transcriptional Axis in the Hippocampus of Learned Helplessness Rats. | Int J Neuropsychopharmacol | 2022 | 36161325 | PubTator, text mining | PubMed |
| Significance of m6A regulatory factor in gene expression and immune function of osteoarthritis. | Front Physiol | 2022 | 36160850 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=90